Specific Binding of [11C]Raclopride and N-[3H]Propyl-Norapomorphine to Dopamine Receptors in Living Mouse Striatum: Occupancy by Endogenous Dopamine and Guanosine Triphosphate–Free G Protein
- 1 May 2002
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 22 (5) , 596-604
- https://doi.org/10.1097/00004647-200205000-00011
Abstract
According to the ternary complex model of G-protein linkage to receptors, agonists increase the affinity of the receptors for the G protein. The model predicts that an endogenous agonist's constant of inhibition toward an agonist radioligand is lower than that toward an antagonistic radioligand. The authors hypothesized that competition from endogenous dopamine in striatum of living mice should have a greater effect on the binding of the D2,3 partial agonist N-[3H]propylnorapomorphine than on the binding of the D2,3 antagonist [11C]raclopride. The baseline binding potential ( pB(0)), defined as the ratio of bound-to-unbound ligand in the absence of competition from endogenous dopamine, was simultaneously measured in mouse striatum for [11C]raclopride ( pB(0) = 8.5) and N-[3H]propylnorapomorphine ( p′B(0) = 5.3). The baseline was established by treatment with α-methyl- p-tyrosine and reserpine. Relative to these baseline values in saline-treated mice, the pB of N-[3H]propylnorapomorphine decreased 52% whereas the pB of [11C]raclopride decreased only 30%, indicating greater sensitivity of the former compound to inhibition by synaptic dopamine. Furthermore, amphetamine decreased the pB of N-[3H]propylnorapomorphine to a greater extent (73%) than that of [11C]raclopride (43%) relative to the reserpine condition. For both radioligands, the occupancy of the dopamine receptors by endogenous agonist obeyed Michaelis-Menten kinetics over a wide range of agonist concentrations established by the pharmacologic treatments. The apparent inhibition constant of endogenous dopamine depended on the dopamine occupancy and decreased to a value 1.66 times greater for N-[3H]propylnorapomorphine than for [11C]raclopride at its highest occupancies. The results are consistent with the hypothesis that agonist binding is more sensitive than antagonist binding to competition from endogenous dopamine. Therefore, dopamine agonist ligands may be superior to benzamide antagonist ligands for the estimation of dopamine receptor occupancy by endogenous synaptic dopamine. The analysis of the effect of dopamine occupancy on the inhibition of N-[3H]propylnorapomorphine binding indicated a limited supply of G protein with a maximum ternary complex fraction of 40% of maximum agonist binding capacity.Keywords
This publication has 38 references indexed in Scilit:
- Increased baseline occupancy of D 2 receptors by dopamine in schizophreniaProceedings of the National Academy of Sciences, 2000
- Quantification of Amphetamine-Induced Changes in [11C]Raclopride Binding with Continuous InfusionJournal of Cerebral Blood Flow & Metabolism, 1997
- Pharmacology of Muscarinic Receptor Subtypes Constitutively Activated by G ProteinsMolecular Pharmacology, 1997
- In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphineEuropean Journal of Pharmacology, 1990
- In vivo labeling of brain dopamine D2 receptors using the high-affinity specific D2 agonist [3H]CV 205–502Brain Research, 1988
- Dopamine D2 receptors in the rat brain: autoradiographic visualization using a high-affinity selective agonist ligandJournal of Neuroscience, 1987
- The Benzazepine, SCH 23390, Inhibits 3H‐NPA Binding in Mouse Brain In VivoActa Pharmacologica et Toxicologica, 1986
- Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphineBrain Research, 1986
- [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptorEuropean Journal of Pharmacology, 1982
- Interaction at end-plate receptors between different choline derivativesProceedings of the Royal Society of London. B. Biological Sciences, 1957